SPOTLIGHT: Minerva Biotechnologies fires CEO

Massachusetts-based nanotech firm Minerva Biotechnologies is on the hunt for a new CEO after firing Jim Czirr. Reasons for the termination were not revealed, but the company says it has brought suit against Czirr in Massachusetts Superior Court. Release

Suggested Articles

In this week's EuroBiotech Report, Roche's risdiplam clears another phase 3 SMA trial, Merck KGaA spinout raises cash and Korean VCs back PDC*line.

In our EuroBiotech roundup this week, a liver disease biotech raises €11 million, Autolus offers stock and Abivax plans midphase trial. 

Merck KGaA spinout iOnctura has raised a €15 million series A round to support an early-phase solid tumor trial of a PI3Kδ inhibitor.